arrow
F

Frans Van de Werf

KU Leuven
H指数:119
被引数:6.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rescue percutaneous coronary intervention in the pharmaco-invasive era of ST-elevation myocardial infarction: insights from the STREAM-2 trial

ST段抬高型心肌梗死药溶时代经皮冠状动脉介入治疗的补救措施:STREAM-2试验的启示

2025-12-010
PRE
Pharmaco-Invasive Strategy With Half-Dose Tenecteplase in Patients With STEMI: Prespecified Pooled Analysis of Patients Aged ≥75 Years in STREAM-1 and 2

在STEMI患者中使用半剂量tenectepase的药物侵入性策略: STREAM-1和2中年龄 ≥ 75岁的患者的预设汇总分析

2024-12-010
PRE
Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up
2024-10-010
PRE
STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial
2023-08-2923
OA
Polypill Strategy in Secondary Cardiovascular Prevention
2022-09-15166
OA
Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the-label EURO SHOCK trial
2021-02-0158
OA
Implementing the new European Regulations on medical devices-clinical responsibilities for evidence-based practice: a report from the Regulatory Affairs Committee of the European Society of Cardiology

实施新的欧洲医疗器械法规-循证实践的临床责任: 欧洲心脏病学会管理事务委员会的报告

2020-06-0237
OAAI
Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54
2019-06-2028
OAAI